vidarabine phosphate has been researched along with Acute Hypercapnic Respiratory Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charan, N; Crowley, JJ; Knight, L | 1 |
| Erslev, AJ; Kane, GC; McMichael, AJ; Patrick, H | 1 |
2 other study(ies) available for vidarabine phosphate and Acute Hypercapnic Respiratory Failure
| Article | Year |
|---|---|
Lysis pneumonopathy associated with the use of fludarabine phosphate.
Topics: Adult; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Respiratory Insufficiency; Tumor Lysis Syndrome; Vidarabine Phosphate | 1994 |
Pulmonary toxicity and acute respiratory failure associated with fludarabine monophosphate.
Topics: Acute Disease; Aged; Antimetabolites, Antineoplastic; Humans; Male; Pulmonary Fibrosis; Respiratory Insufficiency; Vidarabine Phosphate | 1992 |